SEPSF 財務： Asep Medical Holdings Inc AI 分析

首頁

股票

SEPSF

SEPSF 財務

Asep Medical Holdings Inc

0%

$0

收盤價：Feb 12, 16:00:00 GMT-5

0%

$0

盤前：Feb 13, 08:48:54 GMT-5

概觀預測收益股利財務狀況

關鍵數據

前收市價

開盤價

當日範圍

52週區間

交易量

平均成交量

每股盈餘 (TTM)

股息收益率

市值

什麼是 SEPSF？

ASEP Medical Holdings, Inc. engages in the acquisition of assets, technology, and businesses in the area of life sciences and medical diagnostics. The company is headquartered in Victoria, British Columbia. The company went IPO on 2021-11-22. The firm consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. The firm offers a rare combination of both a novel diagnostic and a therapeutic approach. The Company’s lead product was developed through its subsidiary, Sepset Biosciences Inc., which utilizes proprietary diagnostic tools to enable the early and timely identification of sepsis. ABT Innovations Inc. provides broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections. SafeCoat Medical Inc. provides an antimicrobial peptide, anti-fouling medical device coating technology.

功能特性

資源

市場

收入

資產負債表

現金流量

年度

每季

SEPSF 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021
營收	0	0	0	0	0
營收年增率 (YoY)	--	--	--	--	--
營收成本	--	--	--	--	--
毛利	--	--	--	--	--
銷售、一般及管理費用	1	2	5	3	1
研發	0	0	0	0	0
營業費用	2	4	7	5	2
其他非營業收入 (費用)	0	--	--	0	--
稅前淨利	-12	-13	-9	-5	-2
所得稅費用	--	--	0	0	--
淨利	-7	-8	-8	-4	-2
淨利成長	75%	0%	100%	100%	--
稀釋後流通股數	11.12	7.6	6.22	6.21	5.61
股數年變動 (YoY)	46%	22%	0%	11%	--
每股盈餘 (稀釋)	-0.7	-1.08	-1.32	-0.72	-0.39
每股盈餘成長率	17%	-18%	82%	87%	--
自由現金流	0	0	-2	-3	-1
每股自由現金流	--	--	--	--	--
毛利率	--	--	--	--	--
營業利益率	0%	0%	0%	0%	0%
淨利率	0%	0%	0%	0%	0%
自由現金流利潤率	0%	0%	0%	0%	0%
EBITDA	-2	-2	-6	-4	-2
EBITDA 利潤率	0%	0%	0%	0%	0%
EBITDA 中的折舊與攤銷	0	1	1	1	0
EBIT	-2	-3	-7	-5	-2
EBIT 利潤率	0%	0%	0%	0%	0%
有效稅率	--	--	0%	0%	--

Asep Medical Holdings Inc（SEPSF）價格

SEPSF 股價走勢圖